FindTrial
Sign In

Clinical study of Ganciclovir Ophthalmic in situ forming Gel

Clinical study of Ganciclovir Ophthalmic in situ forming Gel

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17014005
Enrollment
Unknown
Registered
2017-12-17
Start date
2008-12-23
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes Simplex Keratitis

Interventions

experiment group:Ganciclovir Ophthalmic in situ forming Gel
control group: Ganciclovir Ophthalmic Gel

Sponsors

Eye and ENT Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who were clinical diagnosed of herpes simplex keratitis with punctate dendritic or map shaped change in the cornea; 2. Aged 18 to 65 years; 3. Sex was unlimited; 4. Patients should understand and sign informed consent.

Exclusion criteria

Exclusion criteria: Pregnancy or lactation woman

Design outcomes

Primary

MeasureTime frame
Effectiveness;Safety;—

Countries

China

Contacts

Public ContactXinghuai Sun

Eye and ENT Hospital of Fudan University

xhsun@shmu.edu.cn+86 021-64377134

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026